Holen Sie sich die Stockscreener-App
12.09
2.50%
-0.31
Vorhandelsmarkt:
11.96
-0.13
-1.08%
Schlusskurs vom Vortag:
$12.40
Offen:
$12.05
24-Stunden-Volumen:
313.83K
Relative Volume:
0.45
Marktkapitalisierung:
$1.51B
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$5.00M
KGV:
1,209.00
EPS:
0.01
Netto-Cashflow:
$-383.00M
1W Leistung:
-3.28%
1M Leistung:
+5.59%
6M Leistung:
+18.65%
1J Leistung:
-21.49%
1-Tages-Spanne:
$11.72
$12.17
1-Wochen-Bereich:
$11.72
$12.58
52-Wochen-Spanne:
$7.33
$23.22
Indivior Plc Stock (INDV) Company Profile
Vergleichen Sie INDV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
12.09 | 1.51B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
165.02 | 74.45B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.49 | 42.91B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.24 | 41.98B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.49 | 24.35B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
11.96 | 14.28B | 15.05B | -883.30M | 1.89B | -0.74 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-23 | Eingeleitet | Piper Sandler | Overweight |
| 2024-04-03 | Eingeleitet | Craig Hallum | Buy |
| 2023-07-13 | Eingeleitet | Northland Capital | Outperform |
Indivior Plc Aktie (INDV) Neueste Nachrichten
Indivior transitions to US GAAP reporting for investor interest By Investing.com - Investing.com Canada
Indivior Transitions to US GAAP for Enhanced Market Positioning - TipRanks
Madison Avenue Partners Increases Stake in Indivior PLC - TipRanks
Naloxone Market Future Business Opportunities 2025-2032 | - openPR
Objective long/short (INDV) Report - Stock Traders Daily
Indivior Announces Total Voting Rights and Capital Update - TipRanks
Indivior (NASDAQ:INDV) Shares Gap UpTime to Buy? - MarketBeat
Indivior PLC Experiences Change in Major Shareholdings - TipRanks
Indivior Advances Shareholder Value with Share Repurchase - TipRanks
Indivior Executes Share Repurchase Under $100 Million Program - TipRanks
Indivior Insiders Sold US$7.9m Of Shares Suggesting Hesitancy - Simply Wall St
Indivior Announces Share Repurchase and Cancellation - TipRanks
Indivior : NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM Form 6 K - Marketscreener.com
Indivior Director Acquires Significant Shareholding - TipRanks
Indivior's Motion to Dismiss Suboxone Lawsuits - LawyersandSettlements.com
Indivior CFO steps down from board after discussions with Oaktree Capital - MSN
Indivior CFO steps down amid Oaktree pressure (INDV:NASDAQ) - Seeking Alpha
Indivior reshuffles board under Oaktree pressure - Reuters
Indivior's (INDV) "Buy" Rating Reaffirmed at Jefferies Financial Group - MarketBeat
Indivior appoints new board members, CFO to step down; shares drop - Investing.com
Indivior makes board changes after move to Nasdaq - ShareCast
Indivior PLC Restructures Board to Enhance Shareholder Value - TipRanks
Indivior reshuffles board as CFO exits under Oaktree pressure - Marketscreener.com
Drugmaker Indivior's finance chief Preblick to step down - Marketscreener.com
Indivior Advances Share Repurchase Initiative - TipRanks
Trend Tracker for (INDV) - Stock Traders Daily
Indivior PLC (NASDAQ:INDV) Shares Sold by Barclays PLC - MarketBeat
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Indivior PLC(INDV) Shareholders - The Eastern Progress Online
Representative actions in securities claims: Court of Appeal hears Wirral Council v Indivior PLC/Reckitt Benckiser Group PLC - Stewarts Law
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit - The Eastern Progress Online
Naloxone Market Overall Study Report 2024-2031 | EMERGENT, - openPR
Opioid Use Disorder Market: Share, Key Trends, Growth Drivers, - openPR
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
Suboxone Market Key Trends, Segments, and Fastest Growing - openPR
Indivior (LON:INDV) Shares Down 1.2%Should You Sell? - MarketBeat
Indivior PLC Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 1, 2024 to Discuss Your RightsINDV - The Eastern Progress Online
Indivior (LON:INDV) shareholder returns have been enviable, earning 366% in 5 years - Yahoo Finance
Indivior Announces Q3 2024 Financial Results - The Eastern Progress Online
Indivior Announces Q3 2023 Financial Results - GuruFocus.com
Investors Bid To Revive Suboxone Representative Claim - Law360
Indivior Enhances Shareholder Value with Buyback - TipRanks
Reckitt Investors To Test Class-Action Rules In Opioid Case - Law360
XTX Topco Ltd Boosts Position in Indivior PLC (NASDAQ:INDV) - MarketBeat
Finanzdaten der Indivior Plc-Aktie (INDV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.12%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):